Connable Office Inc Baxter International Inc Transaction History

Connable Office Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$78.33 - $90.73 $1.5 Million - $1.74 Million	-19,124 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$78.66 - $94.14 $133,014 - $159,190	-1,691 Reduced 8.12%	19,124 $1.65 Million
Q1 2020 May 08, 2020	BUY	$71.57 - $93.3 $479,232 - $624,736	6,696 Added 47.43%	20,815 $1.69 Million
Q4 2019 Feb 07, 2020	SELL	$76.7 - $88.45 $1.16 Million - $1.33 Million	-15,070 Reduced 51.63%	14,119 $1.18 Million
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $9,035 - $9,965	-111 Reduced 0.38%	29,189 $2.55 Million
Q1 2019 May 07, 2019	BUY	$64.48 - $81.31 $22,890 - $28,865	355 Added 1.23%	29,300 $2.38 Million
Q4 2018 Feb 12, 2019	SELL	$61.45 - $77.8 $3,133 - $3,967	-51 Reduced 0.18%	28,945 $1.91 Million
Q3 2018 Nov 06, 2018	SELL	$70.71 - $77.75 $27,294 - $30,011	-386 Reduced 1.31%	28,996 $2.24 Million
Q1 2018 May 08, 2018	BUY	$62.56 - $72.26 $14,451 - $16,692	231 Added 0.79%	29,382 $1.91 Million
Q4 2017 Feb 07, 2018	SELL	$61.45 - $66.05 $631,644 - $678,927	-10,279 Reduced 26.07%	29,151 $1.88 Million
Q3 2017 Nov 03, 2017	BUY	$59.5 - $64.61 $2.35 Million - $2.55 Million	39,430	39,430 $2.47 Million

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

Stay updated on Connable Office Inc with notifications on news.